HRP20141243T1 - Upotreba escina - Google Patents
Upotreba escina Download PDFInfo
- Publication number
- HRP20141243T1 HRP20141243T1 HRP20141243TT HRP20141243T HRP20141243T1 HR P20141243 T1 HRP20141243 T1 HR P20141243T1 HR P20141243T T HRP20141243T T HR P20141243TT HR P20141243 T HRP20141243 T HR P20141243T HR P20141243 T1 HRP20141243 T1 HR P20141243T1
- Authority
- HR
- Croatia
- Prior art keywords
- use according
- disease
- allergy
- escin
- preparation
- Prior art date
Links
- 229940011399 escin Drugs 0.000 title claims 5
- 229930186222 escin Natural products 0.000 title claims 5
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 206010020751 Hypersensitivity Diseases 0.000 claims 5
- 208000026935 allergic disease Diseases 0.000 claims 5
- 230000007815 allergy Effects 0.000 claims 5
- 210000003714 granulocyte Anatomy 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- AXNVHPCVMSNXNP-IVKVKCDBSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,9r,10r,12as,14ar,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(e)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(C[C@H]14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AXNVHPCVMSNXNP-IVKVKCDBSA-N 0.000 claims 1
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 208000004262 Food Hypersensitivity Diseases 0.000 claims 1
- 206010016946 Food allergy Diseases 0.000 claims 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 claims 1
- 208000028622 Immune thrombocytopenia Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 206010040070 Septic Shock Diseases 0.000 claims 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 206010046752 Urticaria Pigmentosa Diseases 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 201000009961 allergic asthma Diseases 0.000 claims 1
- 208000002205 allergic conjunctivitis Diseases 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 claims 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 claims 1
- 210000003651 basophil Anatomy 0.000 claims 1
- 229940093314 beta-escin Drugs 0.000 claims 1
- AXNVHPCVMSNXNP-BEJCRFBNSA-N beta-escin Natural products CC=C(/C)C(=O)O[C@H]1[C@H](OC(=O)C)[C@]2(CO)[C@H](O)C[C@@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@H]6O[C@@H]([C@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@@H]6O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)C(=O)O)[C@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2CC1(C)C AXNVHPCVMSNXNP-BEJCRFBNSA-N 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 230000035622 drinking Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000003979 eosinophil Anatomy 0.000 claims 1
- 235000020932 food allergy Nutrition 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- -1 gums Substances 0.000 claims 1
- 210000003630 histaminocyte Anatomy 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000007937 lozenge Substances 0.000 claims 1
- 208000030179 maculopapular cutaneous mastocytosis Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 210000000440 neutrophil Anatomy 0.000 claims 1
- 235000010603 pastilles Nutrition 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 208000037921 secondary disease Diseases 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 201000003067 thrombocytopenia due to platelet alloimmunization Diseases 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
Claims (13)
1. Upotreba escina za proizvodnju farmaceutskog preparata za liječenje bolesti, naznačena time što je izvor bolesti posredovan ili uzrokovan aktiviranim granulocitima.
2. Upotreba temeljem zahtjeva 1, naznačena time što je escin beta-escin.
3. Upotreba temeljem zahtjeva 1 ili 2, naznačena time što su granulociti hiperaktivirani.
4. Upotreba temeljem bilo kojeg od zahtjeva 1 do 3, naznačena time što je bolest alergija ili alergijska sekundarna bolest.
5. Upotreba temeljem bilo kojeg od zahtjeva 1 do 4, naznačena time što je bolest alergija tipa I ili tipa III ili septički šok, poželjno alergija tipa I.
6. Upotreba temeljem bilo kojeg od zahtjeva 1 do 5, naznačena time što je bolest izabrana između alergijskog rinitisa, urtikarije pigmentoze, atopijskog dermatitisa, alergijske astme, alergije na hranu, alergijskog konjuktivitisa, alergije crijevnog trakta i alergije ušiju.
7. Upotreba temeljem bilo kojeg od zahtjeva 1 do 5, naznačena time što je bolest izabrana između psorijaze, artritisa, imune trombocitopenije, autoimune hemolitičke anemije, sistemske lupus eritematoze, reumatoidnog artritisa, dijabetesa tipa I i multiple skleroze.
8. Upotreba temeljem bilo kojeg od zahtjeva 1 do 7, naznačena time što su granulociti izabrani između eozinofila, neutrofila, bazofila i mastocita.
9. Upotreba temeljem bilo kojeg od zahtjeva 1 do 8, naznačena time što je preparat u obliku perparat za topikalnu ili mukozalnu upotrebu, poželjno losiona za kožu, krema, prašaka, sprejeva ili otopina za ispiranje grla.
10. Upotreba temeljem bilo kojeg od zahtjeva 1 do 9, naznačena time što je preparat u obliku za oralni unos, poželjno u obliku pastila, tableta, guma, pastila, prašaka ili otopina za piće.
11. Upotreba temeljem bilo kojeg od zahtjeva 1 do 10, naznačena time što preparat uključuje farmaceutske nosače, ekscipijente, poželjno polimerske ekscipijente, ili aditive.
12. Upotreba temeljem bilo kojeg od zahtjeva 1 do 4, naznačena time što je escin u dozama između 0.01 mg/kg i 500 mg/kg, poželjno između 0.1 mg/kg i 100 mg/kg, najpoželjnije između 1 mg/kg i 40 mg/kg.
13. Escin za upotrebu u liječenju kako je definiran u bilo kojem od zahtjeva 1 do 12.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06450109A EP1884245A1 (en) | 2006-08-04 | 2006-08-04 | Use of Escin |
| EP07786539.2A EP2046345B1 (en) | 2006-08-04 | 2007-08-03 | Use of escin |
| PCT/EP2007/006870 WO2008015007A2 (en) | 2006-08-04 | 2007-08-03 | Use of escin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20141243T1 true HRP20141243T1 (hr) | 2015-02-13 |
Family
ID=37969918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20141243TT HRP20141243T1 (hr) | 2006-08-04 | 2014-12-22 | Upotreba escina |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20100227830A1 (hr) |
| EP (2) | EP1884245A1 (hr) |
| JP (1) | JP5345933B2 (hr) |
| KR (1) | KR20090034946A (hr) |
| CN (1) | CN101500582B (hr) |
| AU (1) | AU2007280625B2 (hr) |
| BR (1) | BRPI0715070B8 (hr) |
| CA (1) | CA2658279C (hr) |
| DK (1) | DK2046345T3 (hr) |
| EA (1) | EA015404B1 (hr) |
| ES (1) | ES2531516T3 (hr) |
| HR (1) | HRP20141243T1 (hr) |
| IL (1) | IL196606A (hr) |
| MX (1) | MX2009000991A (hr) |
| NZ (1) | NZ574249A (hr) |
| PL (1) | PL2046345T3 (hr) |
| PT (1) | PT2046345E (hr) |
| SI (1) | SI2046345T1 (hr) |
| UA (1) | UA94954C2 (hr) |
| WO (1) | WO2008015007A2 (hr) |
| ZA (1) | ZA200900372B (hr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2303287T3 (en) * | 2008-07-01 | 2014-02-17 | Marinomed Biotechnologie Gmbh | Antiallergic marine biopolymers |
| EP2186523A1 (en) * | 2008-11-18 | 2010-05-19 | Marinomed Biotechnologie GmbH | Use of escin for treatment of Type IV hypersensitivity reaction |
| ES2346844A1 (es) * | 2010-03-17 | 2010-10-20 | Ricardo Lombardero Calzon | Crema para quemaduras. |
| WO2012101618A1 (en) | 2011-01-28 | 2012-08-02 | Barcelcom Têxteis S.A. | Compression stockings and tubes with bioactive agents for the treatment of venous insufficiency and varicose veins |
| CN105050580B (zh) | 2013-03-15 | 2017-11-28 | 玫琳凯有限公司 | 化妆品组合物及其用途 |
| US9801900B2 (en) | 2013-11-22 | 2017-10-31 | Mary Kay Inc. | Compositions for sensitive skin |
| CN104147055A (zh) * | 2014-07-08 | 2014-11-19 | 武汉爱民制药有限公司 | 赖氨酸七叶皂苷及其盐在制备治疗i型超敏反应药物中的用途 |
| US20180154777A1 (en) * | 2016-12-02 | 2018-06-07 | Faraday&Future Inc. | Braking torque blending system and method for automatic emergency braking |
| IT202100014495A1 (it) * | 2021-06-08 | 2022-12-08 | Neilos S R L | "Composizione per l’uso nella prevenzione e/o nel trattamento di patologie osteoarticolari" |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1676561U (de) | 1954-03-27 | 1954-05-20 | Lutz Kg Maschf Eugen | Vorrichtung zum fraesen von nuten u. dgl. mittels einer motor-oberfraese. |
| DE3402259A1 (de) * | 1984-01-24 | 1985-08-01 | Stephan Dr.med. 3000 Hannover Regöczy | Therapeutisch wirksames gemisch, insbesondere zur behandlung von infektionskrankheiten im hals-, nasen- ohrenbereich, stimmbandentzuendungen, schwerer heiserkeit und trombophlebitis |
| DE3445324A1 (de) * | 1984-12-12 | 1986-06-12 | Klinge Pharma GmbH, 8000 München | Arzneimittelkombination mit synergistischer wirkung |
| IT1252866B (it) | 1991-12-31 | 1995-06-28 | Lifegroup Spa | N-acilderivati di aminoalcooli con acidi policarbossilici atti alla modulazione dei mastociti nei processi infiammatori su base neuroimmunogenica |
| US6800746B2 (en) * | 1997-02-25 | 2004-10-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6894146B1 (en) * | 1997-02-25 | 2005-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6943236B2 (en) * | 1997-02-25 | 2005-09-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US7033827B2 (en) * | 1997-02-25 | 2006-04-25 | Corixa Corporation | Prostate-specific polynucleotide compositions |
| US6630305B1 (en) * | 1999-11-12 | 2003-10-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6759515B1 (en) * | 1997-02-25 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US7049063B2 (en) * | 1998-03-18 | 2006-05-23 | Corixa Corporation | Methods for diagnosis of lung cancer |
| US6504010B1 (en) * | 1999-06-30 | 2003-01-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6858204B2 (en) * | 1999-06-30 | 2005-02-22 | Corxia Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6509448B2 (en) * | 1999-06-30 | 2003-01-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
-
2006
- 2006-08-04 EP EP06450109A patent/EP1884245A1/en not_active Withdrawn
-
2007
- 2007-08-03 MX MX2009000991A patent/MX2009000991A/es active IP Right Grant
- 2007-08-03 US US12/376,419 patent/US20100227830A1/en not_active Abandoned
- 2007-08-03 PL PL07786539T patent/PL2046345T3/pl unknown
- 2007-08-03 ES ES07786539.2T patent/ES2531516T3/es active Active
- 2007-08-03 PT PT77865392T patent/PT2046345E/pt unknown
- 2007-08-03 BR BRPI0715070A patent/BRPI0715070B8/pt not_active IP Right Cessation
- 2007-08-03 CA CA2658279A patent/CA2658279C/en active Active
- 2007-08-03 NZ NZ574249A patent/NZ574249A/en not_active IP Right Cessation
- 2007-08-03 DK DK07786539.2T patent/DK2046345T3/en active
- 2007-08-03 KR KR1020097002110A patent/KR20090034946A/ko not_active Application Discontinuation
- 2007-08-03 SI SI200731602T patent/SI2046345T1/sl unknown
- 2007-08-03 JP JP2009523182A patent/JP5345933B2/ja not_active Expired - Fee Related
- 2007-08-03 UA UAA200900868A patent/UA94954C2/uk unknown
- 2007-08-03 EP EP07786539.2A patent/EP2046345B1/en active Active
- 2007-08-03 WO PCT/EP2007/006870 patent/WO2008015007A2/en active Application Filing
- 2007-08-03 AU AU2007280625A patent/AU2007280625B2/en not_active Ceased
- 2007-08-03 CN CN200780029119XA patent/CN101500582B/zh active Active
- 2007-08-03 EA EA200900261A patent/EA015404B1/ru not_active IP Right Cessation
-
2009
- 2009-01-16 ZA ZA2009/00372A patent/ZA200900372B/en unknown
- 2009-01-20 IL IL196606A patent/IL196606A/en not_active IP Right Cessation
-
2014
- 2014-12-22 HR HRP20141243TT patent/HRP20141243T1/hr unknown
-
2016
- 2016-09-30 US US15/281,635 patent/US9993512B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20100227830A1 (en) | 2010-09-09 |
| BRPI0715070A2 (pt) | 2013-06-25 |
| PT2046345E (pt) | 2014-12-26 |
| IL196606A0 (en) | 2009-11-18 |
| UA94954C2 (uk) | 2011-06-25 |
| WO2008015007A2 (en) | 2008-02-07 |
| BRPI0715070B8 (pt) | 2021-05-25 |
| EA200900261A1 (ru) | 2009-06-30 |
| IL196606A (en) | 2015-08-31 |
| US20170014465A1 (en) | 2017-01-19 |
| NZ574249A (en) | 2011-04-29 |
| EA015404B1 (ru) | 2011-08-30 |
| AU2007280625B2 (en) | 2012-05-17 |
| CN101500582B (zh) | 2011-08-24 |
| ES2531516T3 (es) | 2015-03-16 |
| EP1884245A1 (en) | 2008-02-06 |
| CN101500582A (zh) | 2009-08-05 |
| DK2046345T3 (en) | 2015-01-26 |
| JP5345933B2 (ja) | 2013-11-20 |
| US9993512B2 (en) | 2018-06-12 |
| MX2009000991A (es) | 2009-04-16 |
| PL2046345T3 (pl) | 2015-05-29 |
| SI2046345T1 (sl) | 2015-03-31 |
| CA2658279A1 (en) | 2008-02-07 |
| WO2008015007A3 (en) | 2008-04-03 |
| EP2046345A2 (en) | 2009-04-15 |
| JP2009545623A (ja) | 2009-12-24 |
| ZA200900372B (en) | 2009-12-30 |
| AU2007280625A1 (en) | 2008-02-07 |
| EP2046345B1 (en) | 2014-12-10 |
| KR20090034946A (ko) | 2009-04-08 |
| BRPI0715070B1 (pt) | 2021-04-13 |
| CA2658279C (en) | 2014-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20141243T1 (hr) | Upotreba escina | |
| Rao et al. | Aegle marmelos leaf extract and plant surfactants mediated green synthesis of Au and Ag nanoparticles by optimizing process parameters using Taguchi method | |
| ITRE20040112A1 (it) | Impianto scagliatore per la produzione di scaglie di polveri fini | |
| Mishra | Isolation, spectroscopic characterization and computational modeling of chemical constituents of Piper longum natural product | |
| WO2008100635A8 (en) | 1- [3- (monocyclic amino) propyl] - 4, 5, 6, 7-tetrahydro-1h-pyrazolo [4, 3-c] -pyridines as modulators of cathepsin s | |
| TH95236B (th) | อุปกรณ์ควบคุมระยะไกล | |
| TH96425B (th) | อุปกรณ์ติดต่อสื่อสารภายใน | |
| TH95639S (th) | ชุดฝักบัว | |
| TH85974S (th) | ภาชนะบรรจุ | |
| TH89256S (th) | ลำโพง | |
| TH93335S (th) | ที่คนเครื่องดื่ม | |
| TH97605B (th) | อุปกรณ์ชี้สำหรับคอมพิวเตอร์ | |
| TH97608B (th) | อุปกรณ์ชี้สำหรับคอมพิวเตอร์ | |
| TH97609B (th) | อุปกรณ์ชี้สำหรับคอมพิวเตอร์ | |
| TH97607B (th) | อุปกรณ์ชี้สำหรับคอมพิวเตอร์ | |
| TH97606B (th) | อุปกรณ์ชี้สำหรับคอมพิวเตอร์ | |
| TH96491B (th) | อุปกรณ์ควบคุมไฟฟ้า | |
| TH127822B (th) | สารรวมต้านเนื้องอกที่ประกอบด้วยแอนติบอดีที่จดจำ cd38 อย่างจำเพาะและ ไซทาราบีน | |
| TH99099B (th) | อุปกรณ์แปลงสัญญาณสำหรับเครื่องเสียงแบบพกพา | |
| TH127650S (th) | เตียง | |
| TH135357S (th) | เตียง | |
| TH75012EX (th) | สวิทช์ | |
| TH102880S (th) | บานประตู | |
| TH78209EX (th) | โทรศัพท์ | |
| TH82481B (th) | สวิทซ์ไฟ |